Kymera Therapeutics vs Universal Health Services

Kymera Therapeutics (KYMR), health care, and Universal Health Services (UHS), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Universal Health Services is worth $11.1B on the stock market and Kymera Therapeutics $10.4B: Universal Health Services is valued at 7% more. Kymera Therapeutics's operating margin in its latest fiscal year was -891% and Universal Health Services's 11.5%. Over the past year Kymera Therapeutics's share price has moved +95.7% and Universal Health Services's -13.6%.

Key facts

Kymera Therapeutics market value
$10.4B
Universal Health Services market value
$11.1B
Universal Health Services P/E
8.3
Kymera Therapeutics revenue
$39.2MFY to 2025-12-31
Universal Health Services revenue
$17.4BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Kymera Therapeutics vs Universal Health Services: every measure side by side
Measure Kymera Therapeutics Universal Health Services
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$10.4Blower$11.1Bhigher
Revenue$39.2Mlower$17.4Bhigher
Earnings-$311.4Mlower$1.5Bhigher
Employees285lower102,000higher
Total assets$1.7Blower$15.5Bhigher
Valuation
P/E—8.3
P/S265higher0.6lower
P/B6.4higher1.5lower
Dividend yield0.00%lower0.40%higher
Profitability
Operating margin-891%lower11.5%higher
Balance sheet
Net assets$1.6Blower$7.3Bhigher
Total liabilities$163.1Mlower$8.1Bhigher
Total debt—$4.8B
Cash on hand$357Mhigher$137.8Mlower
Price change
Today-3.44%lower-2.94%higher
1 year+95.7%higher-13.6%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Kymera Therapeutics only (1)

Universal Health Services only (5)

Percentages are each holding's share of that investor's reported portfolio. Who owns KYMR · Who owns UHS

Further comparisons

Learn

Questions and answers

Which is bigger, Kymera Therapeutics or Universal Health Services?

By market value, Universal Health Services is the larger: $11.1B against $10.4B for Kymera Therapeutics. By revenue in its latest fiscal year, Universal Health Services is the larger: $17.4B against $39.2M for Kymera Therapeutics.

Which has the higher operating margin?

Universal Health Services: 11.5%, against -891% for Kymera Therapeutics. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Universal Health Services: 0.40%, against 0.00% for Kymera Therapeutics. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Kymera Therapeutics and Universal Health Services?

None of the tracked superinvestors holds both in their latest 13F filing. 1 holds Kymera Therapeutics and 5 hold Universal Health Services.

Cite this page

Funkfolio, “Kymera Therapeutics vs Universal Health Services”, data as of 18 November 2026. https://funkfolio.com/compare/kymr-vs-uhs

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.